Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Patout, V. Brunel, M. Salaun, S. Bota, L. Thiberville (Rouen, France). Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer. Eur Respir J 2011; 38: Suppl. 55, 2804

Member's Comments

No comment yet.

Related content which might interest you: Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 TNFα as a prognostic factor in surgically treated non-small cell lung carcinomas Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007 Trail receptors as prognostic factors in non-small cell lung cancer Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 COX-2 as prognostic factor in lung cancer: systematic review of the literature with meta-analysis Source: Annual Congress 2005 - Prognostic factors in lung cancer Year: 2005 Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 669s Year: 2007 Bcl-2 as a prognostic factor for survival in small-cell lung cancer Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Risk factor for survival in never-smokers non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 Lung cancer Source: Respipedia Article Year: 2018 Prognostic factors for unresectable non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 270s Year: 2002 Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006 The impact of neuroendocrine differentiation in the prognosis of non-small cell lung cancer Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Effect of comorbidity on the prognosis of non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006 Breast metastasis in association with non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 538s Year: 2005 Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Staging of lung cancer Source: Eur Respir Mon; 2009: 44: 150–168 Year: 2009 Prognostic factors in non-small cell lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Apelin expression is a prognostic factor in non-small cell lung cancer Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 COPD is a risk factor for squamous cell histotype in smokers who develop nonsmall cell lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 361s Year: 2003